Fibroblast growth factor (FGF)-21 based therapies: A magic bullet for nonalcoholic fatty liver disease (NAFLD)?
Expert Opinion on Investigational Drugs | January 17, 2020 | Volume: 29 | Issue: 2 | Pages: 197-204
10.1080/13543784.2020.1718104
| PMID 31948295